Translational Training Program in Pulmonary Biology and Medicine
肺生物学和医学转化培训计划
基本信息
- 批准号:10555370
- 负责人:
- 金额:$ 74.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-07-01 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
SUMMARY/ABSTRACT
This competitive renewal occurs as our T32 Translational Training Program in Pulmonary Biology and
Medicine enters its thirty-fifth year of training researchers, physician-scientists, and visionary leaders. The
Division of Pulmonary, Allergy and Critical Care Medicine (PACCM) provides an outstanding training
environment and mentorship pool with a critical mass of collaborative basic, translational, and clinical
researchers in pulmonary biology and medicine led by internationally recognized scientists. Our goal is to
train the next generation of academic leaders in pulmonary medicine, and our program is designed to provide
outstanding education and cutting-edge research training with a comprehensive, structured, and individualized
career development approach. Our T32 will leverage the expertise and commitment of our diverse faculty to
ensure comprehensive training across the spectrum of pulmonary diseases using innovative technology,
computational skill, extensive patient cohorts, databases, and biorepositories to impact lung health and train
future pulmonary scientists. With eight postdoctoral trainee slots, our T32 places a significant emphasis on
training physician-scientists as well as PhD scientists over a two- to three-year training period. The research
training is a structured milestone-driven program that includes: a three-day, off-campus fellows research
retreat; translational core competencies; academic survival skills series; diversity, equity, and inclusion
training; optional month-long exposures to regulatory activities and drug development at Pitt start-ups; F/K-
level and K-to-R grant workshops; a successful grant review program; academic coaching; and a rigorous
program in responsible conduct of research. Our training plan is structured around individualized
development plans that emphasize quantifiable outcomes (publications, career development awards,
completion of didactic courses and graduate programs, transition to research and academic careers). The
next generation of academic leaders in Pulmonary Medicine needs to have access to skills in evolving
technologies at the bench, sophisticated computation and ‘omics approaches, large patient cohorts and data
analytics, and integration of social determinants of health. Our renewal offers several new initiatives including
emphasizing the cross-cutting themes in lung diseases of aging, health services and disparities, microbiome and
infections, and immunology and inflammation. Other initiatives include dedicated statistical training, expanded
training and collaborations in advanced computational and systems biology approaches, access to novel
lung tissue modeling techniques, career coaching, and a diversity and inclusion curriculum. We have the
trainee pool, leadership, advisory boards, training faculty, and infrastructure to build on an already rich and
successful translational training program and ensure continued development of the next generation of
biomedical researchers in pulmonary disease.
总结/摘要
这种竞争性的更新发生在我们的T32肺生物学转化培训计划,
医学进入其培训研究人员,医生科学家和有远见的领导者的第三十五个年头。的
肺,过敏和重症监护医学部(PACCM)提供出色的培训
环境和指导池,具有协作基础,翻译和临床的临界质量
由国际公认的科学家领导的肺生物学和医学研究人员。我们的目标是
培养下一代肺部医学的学术领袖,我们的计划旨在提供
卓越的教育和前沿的研究培训,全面,结构化,个性化
职业发展方式。我们的T32将利用我们多元化教师的专业知识和承诺,
确保使用创新技术对各种肺部疾病进行全面培训,
计算技能,广泛的患者队列,数据库和生物储存库,以影响肺部健康和培训
未来的肺科学家我们的T32拥有8个博士后实习生名额,非常重视
在两到三年的培训期内培训医生科学家和博士科学家。研究
培训是一个结构化的里程碑驱动计划,包括:为期三天的校外研究员研究
务虚会;翻译核心能力;学术生存技能系列;多样性,公平性和包容性
培训;可选的长达一个月的监管活动和皮特初创公司的药物开发; F/K-
水平和K到R补助金研讨会;一个成功的补助金审查计划;学术辅导;和一个严格的
在负责任的研究行为的计划。我们的培训计划是围绕个性化
强调可量化成果的发展计划(出版物,职业发展奖,
完成教学课程和研究生课程,过渡到研究和学术生涯)。的
下一代肺部医学的学术领导者需要获得不断发展的技能,
实验室技术、复杂的计算和组学方法、大型患者队列和数据
分析和整合健康的社会决定因素。我们的更新提供了几个新的举措,包括
强调老龄化肺部疾病、卫生服务和差距、微生物组和
感染,免疫学和炎症。其他举措包括专门的统计培训、扩大
在先进的计算和系统生物学方法的培训和合作,获得新的
肺组织建模技术,职业指导,以及多样性和包容性课程。我们有
培训人才库、领导力、咨询委员会、培训教师和基础设施,以建立一个已经丰富和
成功的翻译培训计划,并确保下一代的持续发展
肺部疾病的生物医学研究人员。
项目成果
期刊论文数量(51)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A retrospective analysis comparing subjects with isolated and coexistent vocal cord dysfunction and asthma.
一项回顾性分析,比较单独和共存声带功能障碍和哮喘的受试者。
- DOI:10.2500/aap.2013.34.3673
- 发表时间:2013
- 期刊:
- 影响因子:2.8
- 作者:Traister,RussellS;Fajt,MerrittL;Whitman-Purves,Emily;Anderson,WilliamC;Petrov,AndrejA
- 通讯作者:Petrov,AndrejA
Do physicians disclose uncertainty when discussing prognosis in grave critical illness?
医生在讨论严重危重疾病的预后时是否会透露不确定性?
- DOI:10.1353/nib.2012.0033
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:Schuster,RachelA;Hong,SeoYeon;Arnold,RobertM;White,DouglasB
- 通讯作者:White,DouglasB
Globins and nitric oxide homeostasis in fish embryonic development.
- DOI:10.1016/j.margen.2019.100721
- 发表时间:2019-11
- 期刊:
- 影响因子:1.9
- 作者:Elizabeth Rochon;P. Corti
- 通讯作者:Elizabeth Rochon;P. Corti
Bosentan for sarcoidosis-associated pulmonary hypertension, age-adjusted D-dimer levels in pulmonary embolism, and mean arterial blood pressure targets in septic shock.
波生坦用于治疗结节病相关的肺动脉高压、肺栓塞中年龄调整的 D-二聚体水平以及感染性休克中的平均动脉血压目标。
- DOI:10.1164/rccm.201407-1305rr
- 发表时间:2014
- 期刊:
- 影响因子:24.7
- 作者:Alvarez,RogerA;Barbash,IanJ;Rose,JasonJ
- 通讯作者:Rose,JasonJ
Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report.
- DOI:10.1007/s10067-022-06126-x
- 发表时间:2022-05
- 期刊:
- 影响因子:3.4
- 作者:Lemoine C;Padilla C;Krampe N;Doerfler S;Morgenlander A;Thiel B;Aggarwal R
- 通讯作者:Aggarwal R
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melanie Koenigshoff其他文献
Melanie Koenigshoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melanie Koenigshoff', 18)}}的其他基金
Non-canonical WNT signaling in emphysema and lung regeneration
肺气肿和肺再生中的非典型 WNT 信号传导
- 批准号:
10381585 - 财政年份:2019
- 资助金额:
$ 74.63万 - 项目类别:
Non-canonical WNT signaling in emphysema and lung regeneration
肺气肿和肺再生中的非典型 WNT 信号传导
- 批准号:
10355698 - 财政年份:2019
- 资助金额:
$ 74.63万 - 项目类别:
相似国自然基金
胚胎脑发育的分子机理:lgl2(late gestation lung 2)蛋白质的生物学功能的研究
- 批准号:30470854
- 批准年份:2004
- 资助金额:18.0 万元
- 项目类别:面上项目
相似海外基金
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训计划
- 批准号:
8313943 - 财政年份:2010
- 资助金额:
$ 74.63万 - 项目类别:
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训计划
- 批准号:
8707544 - 财政年份:2010
- 资助金额:
$ 74.63万 - 项目类别:
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训项目
- 批准号:
10442539 - 财政年份:2010
- 资助金额:
$ 74.63万 - 项目类别:
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训计划
- 批准号:
9756439 - 财政年份:2010
- 资助金额:
$ 74.63万 - 项目类别:
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训项目
- 批准号:
8018012 - 财政年份:2010
- 资助金额:
$ 74.63万 - 项目类别:
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训计划
- 批准号:
8794958 - 财政年份:2010
- 资助金额:
$ 74.63万 - 项目类别:
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训计划
- 批准号:
10696140 - 财政年份:2010
- 资助金额:
$ 74.63万 - 项目类别:
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训项目
- 批准号:
8145305 - 财政年份:2010
- 资助金额:
$ 74.63万 - 项目类别:
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训计划
- 批准号:
8499403 - 财政年份:2010
- 资助金额:
$ 74.63万 - 项目类别:
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训项目
- 批准号:
10269521 - 财政年份:2010
- 资助金额:
$ 74.63万 - 项目类别: